EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Thrombotic Microangiopathy‐Like Phenotype in Patients With Infection‐Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa

Naoki Takezako iD, Fumiyo Komatsu iD, Goichi Honda iD, Noriaki Kawano, Toshimasa Uchiyama, Kazuo Kawasugi, Seiji Madoiwa, Kei Suzuki iD, Yoshinobu Seki iD, Takayuki Ikezoe iD, Kohji Okamoto iD, Hideo Wada iD

European Journal of Haematology · 2026-12 · 117 (6) · 1552-1561

DOI: 10.1111/ejh.70289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 13.08.2026. Verfasst von Naoki Takezako und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Thrombotic Microangiopathies, Thrombomodulin, Infections. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Asahi Kasei Therapeutics Corporation, MIMS Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite disseminated intravascular coagulation (DIC) and thrombotic microangiopathy (TMA) sharing features of thrombocytopenia, organ dysfunction, and bleeding, the relationship between these two conditions remains unclear. We therefore conducted a post hoc analysis of post‐marketing surveillance data from Japan to evaluate the clinical characteristics of 2362 patients with DIC (TMA‐like phenotype DIC, n = 217; and non‐TMA‐like phenotype DIC, n = 2145) who received thrombomodulin alfa (TM‐α). TMA‐like phenotype DIC was defined as platelet count < 15 × 10 4 /μL, hemoglobin < 10 g/dL and lactate dehydrogenase > 500 IU/L. Approximately 9% of the registered infection‐associated cases of DIC were TMA‐like phenotype DIC. Patients with TMA‐like phenotype were younger and had more renal dysfunction and liver dysfunction than those with non‐TMA‐like phenotype. Regarding the hemostatic examinations, fibrin/fibrinogen degradation products, D ‐dimer, and thrombin‐antithrombin complex levels were higher in patients with TMA‐like phenotype than in those with non‐TMA‐like phenotype. Patients with TMA‐like phenotype had worse resolution of DIC and 28‐day survival rates than those with non‐TMA‐like phenotype; however, the coagulation and fibrinolysis parameters in both groups showed improvement after TM‐α administration. These findings describe a clinically severe subgroup of infection‐associated DIC and should be interpreted as exploratory given that confirmatory TMA testing was unavailable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disseminated Intravascular CoagulationThrombotic MicroangiopathiesThrombomodulinInfectionsHumansFemalePhenotypeMaleAgedMiddle AgedAdultTreatment OutcomeAged, 80 and overBlood CoagulationBiomarkers

Stichwörter der Autor:innen

disseminated intravascular coagulationinfectionpostmarketing surveillancethrombocytopeniathrombomodulinthrombotic microangiopathy

Substanzen

ThrombomodulinBiomarkers

Autor:innen und Institutionen

  • Department of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Department of Hematology, Nerima Hikarigaoka Hospital, Tokyo, Japan.
  • Medical Affairs Department, Asahi Kasei Therapeutics Corporation, Tokyo, Japan.
  • Department of Hematology, Fukushima Medical University, Fukushima, Japan.
  • Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
  • Department of Laboratory Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Gunma, Japan.

ORCID-Profile: Naoki Takezako, Fumiyo Komatsu, Goichi Honda, Kei Suzuki, Yoshinobu Seki, Takayuki Ikezoe, Kohji Okamoto, Hideo Wada

Förderung

  • Asahi Kasei Therapeutics Corporation
  • MIMS Co. Ltd

Zitieren

APA

Takezako, N., Komatsu, F., Honda, G., Kawano, N., Uchiyama, T., Kawasugi, K., Madoiwa, S., Suzuki, K., Seki, Y., Ikezoe, T., Okamoto, K., & Wada, H. (2026). Thrombotic Microangiopathy‐Like Phenotype in Patients With Infection‐Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa. European Journal of Haematology, 117(6), 1552-1561. https://doi.org/10.1111/ejh.70289

Vancouver

Takezako N, Komatsu F, Honda G, Kawano N, Uchiyama T, Kawasugi K, et al. Thrombotic Microangiopathy‐Like Phenotype in Patients With Infection‐Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa. European Journal of Haematology. 2026;117(6):1552-1561. doi:10.1111/ejh.70289

BibTeX
@article{Takezako2026,
  author = {Takezako, Naoki and Komatsu, Fumiyo and Honda, Goichi and Kawano, Noriaki and Uchiyama, Toshimasa and Kawasugi, Kazuo and Madoiwa, Seiji and Suzuki, Kei and Seki, Yoshinobu and Ikezoe, Takayuki and Okamoto, Kohji and Wada, Hideo},
  title = {Thrombotic Microangiopathy‐Like Phenotype in Patients With Infection‐Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {117},
  number = {6},
  pages = {1552--1561},
  doi = {10.1111/ejh.70289}
}
Kostenlos starten →